ClinicalTrials.Veeva

Menu

The Impact of Culture in Cognitive Behavior Therapy (CBT) for Patients With Inflammatory Bowel Disease

W

Wang Zhen

Status

Not yet enrolling

Conditions

Cognitive Behavior Therapy
Inflammatory Bowel Disease (IBD)

Treatments

Other: Wait first, then cognitive-behavioral therapy
Other: cognitive-behavioral therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06713694
ZJSRRSH202479337

Details and patient eligibility

About

Introduction Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic condition that affects the gastrointestinal tract and has a significant impact on patients' quality of life (QoL) and mental health(Barberio, Zamani et al. 2021). Cognitive behavioral therapy (CBT) has been recognized as a potential therapeutic approach to address the psychological comorbidities associated with IBD(Seaton, Hudson et al. 2024). However, the effectiveness of CBT in IBD is not solely a clinical issue but is also intertwined with cultural factors that can influence treatment outcomes(Naeem 2019).

The effectiveness of CBT in IBD is not solely a clinical issue but is also intertwined with cultural factors that can influence treatment outcomes . This has implications for the delivery of CBT in IBD care, as cultural beliefs and values can affect help-seeking behaviors and responses to treatment. Cultural factors are integral to the successful implementation of CBT in IBD care(Hinton and Patel 2017, Naeem, Sajid et al. 2023). Further research is needed to understand how cultural adaptations can enhance the efficacy of CBT for IBD patients from diverse backgrounds. It is essential to consider cultural nuances in the development and delivery of CBT to ensure that it is both effective and acceptable to patients with IBD across different cultures.

Objective: To identify gaps in the current understanding of the role of culture in CBT for IBD, including the variety of cultural contexts and IBD populations studied . To provide insights that can guide clinical practice in offering culturally competent CBT to IBD patients and inform policy decisions regarding mental health services for diverse populations with IBD .

Enrollment

40 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients over 18 years of age with diagnosed IBD.
  2. Age: 18 years and older.
  3. residing in China, able to verbally communicate and read in Chinese, with access to the internet to ensure participation in the online intervention.
  4. Able to commit to attend the 6weekly sessions of 1 hours' duration.
  5. No change in antidepressant medication (dose or type) within 3 months of trial onset.

Exclusion criteria

  1. Individuals scheduled for major surgery in the next 3 months.
  2. Current psychological treatment.
  3. Individuals with severe schizophrenia/psychotic disorder.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 4 patient groups

CBT
Experimental group
Treatment:
Other: cognitive-behavioral therapy
CBT-II
Experimental group
Treatment:
Other: cognitive-behavioral therapy
Wait-list
Other group
Treatment:
Other: Wait first, then cognitive-behavioral therapy
Wait-list-II
Other group
Treatment:
Other: Wait first, then cognitive-behavioral therapy

Trial contacts and locations

1

Loading...

Central trial contact

Wang Zhen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems